NCT00325260View on ClinicalTrials.gov

Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China

PHASE3CompletedINTERVENTIONAL

Enrollment

900

Participants

Timeline

Start Date

March 31, 2006

Conditions

Healthy

Interventions

BIOLOGICAL

Influvac; subunit influenza vaccine

Trial Locations (1)

Unknown

Site 1, Nanjing

All Listed Sponsors

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00325260 - Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China | Biotech Hunter | Biotech Hunter